IN2012DN01846A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01846A
IN2012DN01846A IN1846DEN2012A IN2012DN01846A IN 2012DN01846 A IN2012DN01846 A IN 2012DN01846A IN 1846DEN2012 A IN1846DEN2012 A IN 1846DEN2012A IN 2012DN01846 A IN2012DN01846 A IN 2012DN01846A
Authority
IN
India
Prior art keywords
isothiozoles
eye
disclosed
treating conditions
treating
Prior art date
Application number
Inventor
Viswanath Veena
E Donello John
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of IN2012DN01846A publication Critical patent/IN2012DN01846A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Abstract

Disclosed herein are isothiozoles for treating conditions of the eye.
IN1846DEN2012 2009-08-11 2010-08-10 IN2012DN01846A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23304709P 2009-08-11 2009-08-11
PCT/US2010/044946 WO2011019678A1 (en) 2009-08-11 2010-08-10 Isothiozoles for treating conditions of the eye

Publications (1)

Publication Number Publication Date
IN2012DN01846A true IN2012DN01846A (en) 2015-08-21

Family

ID=43007053

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1846DEN2012 IN2012DN01846A (en) 2009-08-11 2010-08-10

Country Status (11)

Country Link
US (1) US20110039900A1 (en)
EP (1) EP2464351A1 (en)
JP (1) JP2013501794A (en)
KR (1) KR20120081585A (en)
CN (1) CN102695505A (en)
AU (1) AU2010282698A1 (en)
BR (1) BR112012003284A8 (en)
CA (1) CA2770894A1 (en)
IN (1) IN2012DN01846A (en)
RU (1) RU2012105453A (en)
WO (1) WO2011019678A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3193867B1 (en) 2014-09-17 2021-01-20 PanOptica, Inc. Ocular formulations for drug-delivery and protection of the anterior segment of the eye
IL251949A0 (en) 2017-04-26 2017-07-31 Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct Small organic molecules for use in the treatment neuroinflammatory disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US6114355A (en) * 1993-03-01 2000-09-05 D'amato; Robert Methods and compositions for inhibition of angiogenesis
US6989451B2 (en) * 2002-06-04 2006-01-24 Valeant Research & Development Heterocyclic compounds and uses thereof
US7956191B2 (en) * 2004-10-20 2011-06-07 Merck Serono Sa 3-arylamino pyridine derivatives
CA2657480A1 (en) * 2006-07-25 2008-01-31 Alcon Research, Ltd. Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders

Also Published As

Publication number Publication date
WO2011019678A1 (en) 2011-02-17
RU2012105453A (en) 2013-09-20
AU2010282698A1 (en) 2012-03-15
US20110039900A1 (en) 2011-02-17
KR20120081585A (en) 2012-07-19
CN102695505A (en) 2012-09-26
CA2770894A1 (en) 2011-02-17
JP2013501794A (en) 2013-01-17
BR112012003284A2 (en) 2016-03-01
BR112012003284A8 (en) 2016-05-17
EP2464351A1 (en) 2012-06-20

Similar Documents

Publication Publication Date Title
MY184101A (en) Indoles
GB201103062D0 (en) Method
MX350661B (en) Yeast-brachyury immunotherapeutic compositions.
MX2014010455A (en) Methods and compositions for treating huntington's disease.
MX2011007572A (en) Reusable outer covers for wearable absorbent articles.
MX2011007930A (en) Crystalline insulin-conjugates.
IN2011KN03851A (en)
EA201171367A1 (en) VINYLINDASOLYL COMPOUNDS
IN2012DN04748A (en)
MX359769B (en) Methods of decellularizing bone.
JO3755B1 (en) Testosterone formulations
IN2012DN04414A (en)
IL216084A0 (en) 2,4-diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
IL213761A0 (en) Novel ortho-aminoamides for the treatment of cancer
GB2498325A (en) Modulation neural pathways
WO2011047091A9 (en) Methods for treating traumatic brain injury
GB2482817A (en) Novel use
EP4023243A3 (en) Compositions and methods for treating celiac sprue disease
IN2011KN03928A (en)
IN2014DN00254A (en)
IN2012DN04412A (en)
MX2012010443A (en) Process for the preparation of 5-substituted 1-alkyltetrazoles.
IN2012DN01846A (en)
MX2011010046A (en) Diaminopteridine derivatives.
WO2013009678A3 (en) Compositions and methods for the treatment of norovirus infection